Younis A Salmean1, Mark S Segal2, Sergiu P Palii3, Wendy J Dahl4. 1. Food Science and Human Nutrition Department, University of Florida, Gainesville, Florida. 2. North Florida/South Georgia Veterans Health System, Gainesville, Florida; Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, Florida. 3. Clinical and Translational Science Institute, College of Medicine, University of Florida, Gainesville, Florida. 4. Food Science and Human Nutrition Department, University of Florida, Gainesville, Florida. Electronic address: wdahl@ufl.edu.
Abstract
OBJECTIVE: To determine the effects of supplemental fiber on plasma p-cresol, stool frequency, and quality of life (QoL) in chronic kidney disease (CKD) patients. DESIGN AND SETTING: In a 12-week single-blind study, participants were provided with control muffins and supplements (5.5 g sucrose/day) for 2 weeks, muffins containing 10 g/day pea hull fiber and control supplements for 4 weeks, and muffins with 10 g/day pea hull fiber and 15 g/day inulin as a supplement for 6 weeks. SUBJECTS:Individuals with CKD (n = 13; 6 males, 7 females; aged 65 ± 3 years; estimated glomerular filtration rate <50 mL/minute/1.73(2)) completed the study. MAIN OUTCOME MEASURES: Plasma p-cresol was determined by gas chromatography-mass spectrometry, stool frequency by 5-day journals, and QoL by the KDQOL-36™. RESULTS:Plasma p-cresol decreased from 7.25 ± 1.74 mg/L during week 1 to 5.82 ± 1.72 mg/L during week 12 (P < .05), and in participants with high compliance (>70% inulin intake), from 6.71 ± 1.98 mg/L to 4.22 ± 1.16 mg/L (P < .05). Total fiber intake increased from 16.6 ± 1.7 g/day during control to 26.5 ± 2.4 g/day (P < .0001) with the added pea hull and to 34.5 ± 2.2 g/day with pea hull and inulin (P < .0001). Stool frequency increased from 1.4 ± 0.2 stools/day during control to 1.9 ± 0.3 stools/day during both fiber periods (P < .05). No change in overall QoL was observed. CONCLUSIONS: Supplementing the diet of CKD patients with fiber may be a dietary therapy to reduce p-cresol and improve stool frequency.
RCT Entities:
OBJECTIVE: To determine the effects of supplemental fiber on plasma p-cresol, stool frequency, and quality of life (QoL) in chronic kidney disease (CKD) patients. DESIGN AND SETTING: In a 12-week single-blind study, participants were provided with control muffins and supplements (5.5 g sucrose/day) for 2 weeks, muffins containing 10 g/day pea hull fiber and control supplements for 4 weeks, and muffins with 10 g/day pea hull fiber and 15 g/day inulin as a supplement for 6 weeks. SUBJECTS: Individuals with CKD (n = 13; 6 males, 7 females; aged 65 ± 3 years; estimated glomerular filtration rate <50 mL/minute/1.73(2)) completed the study. MAIN OUTCOME MEASURES: Plasma p-cresol was determined by gas chromatography-mass spectrometry, stool frequency by 5-day journals, and QoL by the KDQOL-36™. RESULTS: Plasma p-cresol decreased from 7.25 ± 1.74 mg/L during week 1 to 5.82 ± 1.72 mg/L during week 12 (P < .05), and in participants with high compliance (>70% inulin intake), from 6.71 ± 1.98 mg/L to 4.22 ± 1.16 mg/L (P < .05). Total fiber intake increased from 16.6 ± 1.7 g/day during control to 26.5 ± 2.4 g/day (P < .0001) with the added pea hull and to 34.5 ± 2.2 g/day with pea hull and inulin (P < .0001). Stool frequency increased from 1.4 ± 0.2 stools/day during control to 1.9 ± 0.3 stools/day during both fiber periods (P < .05). No change in overall QoL was observed. CONCLUSIONS: Supplementing the diet of CKDpatients with fiber may be a dietary therapy to reduce p-cresol and improve stool frequency.
Authors: Vidya M Raj Krishnamurthy; Guo Wei; Bradley C Baird; Maureen Murtaugh; Michel B Chonchol; Kalani L Raphael; Tom Greene; Srinivasan Beddhu Journal: Kidney Int Date: 2011-10-19 Impact factor: 10.612
Authors: D S Rampton; S L Cohen; V D Crammond; J Gibbons; M F Lilburn; J Y Rabet; A J Vince; J D Wager; O M Wrong Journal: Clin Nephrol Date: 1984-03 Impact factor: 0.975
Authors: R De Smet; F David; P Sandra; J Van Kaer; G Lesaffer; A Dhondt; N Lameire; R Vanholder Journal: Clin Chim Acta Date: 1998-11 Impact factor: 3.786
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Leah Guthrie; Sean Paul Spencer; Dalia Perelman; Will Van Treuren; Shuo Han; Feiqiao Brian Yu; Erica D Sonnenburg; Michael A Fischbach; Timothy W Meyer; Justin L Sonnenburg Journal: Cell Host Microbe Date: 2022-05-27 Impact factor: 31.316
Authors: Raymond Vanholder; Steven Van Laecke; Griet Glorieux; Francis Verbeke; Esmeralda Castillo-Rodriguez; Alberto Ortiz Journal: Toxins (Basel) Date: 2018-06-12 Impact factor: 4.546
Authors: Ruben Poesen; Pieter Evenepoel; Henriette de Loor; Jan A Delcour; Christophe M Courtin; Dirk Kuypers; Patrick Augustijns; Kristin Verbeke; Björn Meijers Journal: PLoS One Date: 2016-04-21 Impact factor: 3.240
Authors: Sarra Elamin; Mariam J Alkhawaja; Amina Y Bukhamsin; Mohamed A S Idris; Muntasir M Abdelrahman; Nasrulla K Abutaleb; Abdulrahman A Housawi Journal: Int J Nephrol Date: 2017-05-14